Dr Kirsten Coupland is the Hunter Medical Research Institute Dalara Early Career Research Fellow in the Translational Stroke Lab at the University of Newcastle and an Affiliate Researcher at the Karolinska Institutet (Sweden). Dr. Coupland has over 10 years’ experience in molecular neuroscience, with particular expertise in identifying novel therapeutic targets. Dr. Coupland’s current research focuses on the important role of cerebrospinal fluid (CSF) composition and dynamics in stroke outcome. Using several different stroke models, in vivo imaging, mass spectrometry, and bioinformatics, Dr. Coupland is carefully piecing together an understanding of the important role CSF plays in long term outcome after stroke. In doing so, she aims to highlight previously unappreciated therapeutics targets to reduce patient disability after stroke. She is also a founder and current co-executive chair of StrokeCORE, a society dedicated to providing a platform for collaboration and knowledge sharing within the pre-clinical stroke research community.